NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF (1621.TSE) — Technical state
As of 2026-09-24 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
Trades +0.6% vs the 50-day and -0.9% vs the 200-day average, 11.6% below the 52-week high and +16.9% off the 52-week low; a death cross printed 55 sessions ago. Computed from daily closes.
The moving-average stack
- vs 20-day-0.4%
- vs 50-day+0.6%
- vs 200-day-0.9%
- 52-week band11.6% off the high · +16.9% off the low
- Streak1 consecutive down session
- CrossoverDeath cross 55 sessions ago
- 50-day crossprice crossed up through the 50-day 2 sessions ago
- Stochastic%K 62.3 · %D 64.1 · bear cross
Continue: the 1621.TSE chart & overview · the signal board
FAQ · from the current data · as of 2026-09-24
Quick answers
What is the current Closelooknet signal on 1621.TSE?
Recovery attempt under the 200-day — Trades +0.6% vs the 50-day and -0.9% vs the 200-day average, 11.6% below the 52-week high and +16.9% off the 52-week low; a death cross printed 55 sessions ago. Computed from daily closes. As of 2026-09-24; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is 1621.TSE above its 50-day and 200-day moving averages?
As of 2026-09-24, NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF trades +0.6% above its 50-day and -0.9% below its 200-day average, with the 20-day -0.4% away.
How far is 1621.TSE from its 52-week high?
11.6% below the 52-week high and 16.9% above the 52-week low, as of 2026-09-24.